Lava Therapeutics, which is developing cancer treatments based on research at Amsterdam University Medical Centers, floated in a $101m offering.
The University of Utah spinout is looking to float on the Nasdaq Global Select Market and has filed with a $100m placeholder amount.
The gene therapy developer focused on cardiovascular and central nervous system diseases will merge with Chardan Healthcare Acquisition 2 Corp to list on NYSE.
Tokyo University of Science is set to exit the recruitment services group in an IPO in Tokyo.
Duke University's contactless security system developer agrees to list through a reverse takeover, providing an exit to OUP.
UW Madison’s small-molecule therapy spinout has raised $170m in venture funding since emerging from stealth less than a year ago.
Hyundai, Kia and GV are contributing to a $350 PIPE in support of a reverse merger that will value the Maryland and Duke-linked company at $2bn.
University of Pennyslvania and Caltech are in line for exits when Stanford’s online education spinout lists on the New York Stock Exchange.
Immuno-oncology therapy developer Lava Therapeutics has filed for a $100m IPO, having been set up in 2016 to exploit Amsterdam University Medical Centers research.
Caltech spinout Talis Biomedical has raised more than $220m in an initial public offering on the Nasdaq Global Market.